Clinical trial harnesses power of natural killer cells to treat neuroblastoma
- OPACC
- Nov 15, 2018
- 1 min read
Now for the first time, scientists will combine NK cell therapy with an immunocytokine to target children with relapsed/refractory neuroblastoma including those with bulky tumors.
Commentaires